Allarity Therapeutics
Quarterly Financials
| Values in thousands | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $112 | $112 |
Gross Profit | -1 | -2 | 103 | |
EBITDA | -12,313 | -1,202 | -3,743 | -4,870 |
EBIT | -12,318 | -1,203 | -3,745 | -4,879 |
Net Income | -12,152 | -1,629 | -3,843 | -1,722 |
Net Change In Cash | 0 | 0 | 112 | 112 |
Free Cash Flow | -5,443 | -7,216 | -1,487 | -1,672 |
Cash | 18,463 | 19,233 | 312 | 166 |
Basic Shares | 1,575 | 499 | 5 | 2,943 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -37 | -120 | -106 | -86 |
EBITDA | -12,083 | -17,236 | -25,910 | -6,013 |
EBIT | -12,120 | -17,356 | -26,016 | -6,099 |
Net Income | -11,901 | -16,058 | -26,648 | -5,073 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Cost of Revenue | -17,337 | |||
Free Cash Flow | -12,745 | -16,835 | -15,050 | -7,254 |
Cash | 166 | 2,029 | 19,555 | 298 |
Basic Shares | 3 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$7.71 |
2024-06-30 | -$3.30 |
2024-03-31 | -$664.20 |
2023-12-31 | -$0.43 |
